Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles

Pharmaceutical Research

Volumn 30, Issue 2, 2013, Pages 552-561

  Dan, Mo ^a,b   Scott, Daniel F ^a   Hardy, Peter A ^c   Wydra, Robert J ^d   Hilt, J Zach ^d   Yokel, Robert A ^a,b   Bae, Younsoo ^a  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

cross linked nanoassemblies; hyperthermia; magnetic resonance imaging; nanoparticles; superparamagnetic iron oxide

Indexed keywords

ASPARAGINASE MACROGOL; CITRIC ACID; COPOLYMER; MAGNETITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENDOTHELIUM CELL; GEL PERMEATION CHROMATOGRAPHY; MAGNETIC FIELD; MATERIAL COATING; MOUSE; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BRAIN; CELL LINE; CELL SURVIVAL; CHEMICAL PRECIPITATION; CITRATES; CROSS-LINKING REAGENTS; HOT TEMPERATURE; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; PARTICLE SIZE; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 84873434943     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0900-8     Document Type: Article

References (65)

1. Satarkar NS, Biswal D, Hilt JZ. Hydrogel nanocomposites: a review of applications as remote controlled biomaterials. Soft Matter. 2010;6:2364-71.
2. Frimpong RA, Hilt JZ. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Nanomedicine. 2010;5:1401-14.
3. Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 2010;70:6303-12.
4. Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery. 2005;57:785-96.
5. Rock JP, Parsa AT, Rutka JT. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor - comments. Neurosurgery. 2005;57:796.
6. Krishnan KM. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE T Magn. 2010;46:2523-58.
7. Silva AC, Oliveira TR, Mamani JB, Malheiros SMF, Malavolta L, Pavon LF, Sibov TT, Amaro E, Tannus A, Vidoto ELG, Martins MJ, Santos RS, Gamarra LF. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed. 2011;6:591-603.
8. Stephen ZR, Kievit FM, Zhang M. Magnetite nanoparticles for medical MR imaging. Mater Today. 2011;14:330-8.
9. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cerebr Blood F Met. 2010;30:15-35.
10. Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol. 2012;5:173-86.
11. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: Ex vivo study. Jpn J Cancer Res. 1997;88:630-2.
12. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63:24-46.
13. Meenach SA, Anderson KW, Hilt JZ. Synthesis and characterization of thermoresponsive poly(ethylene glycol)-based hydrogels and their magnetic nanocomposites. J Polym Sci Pol Chem. 2010;48:3229-35.
14. Cavaliere R, Ciocatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Moricca G, Rossi-Fanelli A. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967;20:1351-81.
15. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neuro-Oncol. 2011;103:317-24.
16. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release. 2011;155:344-57.
17. Lin MM, Kim Do K, El Haj AJ, Dobson J. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE T Nanobiosci. 2008;7:298-305.
18. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26:3995-4021.
19. Farrell D, Majetich SA, Wilcoxon JP. Preparation and characterization of monodisperse Fe nanoparticles. J Phys Chem B. 2003;107:11022-30.
20. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed. 2007;46:1222-44.
21. Lodhia J, Mandarano G, Ferris N, Eu P, Cowell S. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. Biomed Imaging Interv J. 2010;6:e12.
22. Novotna B, Jendelova P, Kapcalova M, Rossner P, Turnovcova K, Bagryantseva Y, Babic M, Horak D, Sykova E. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol Lett. 2012;210:53-63.
23. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev. (2011).
24. Beduneau A, Ma Z, Grotepas CB, Kabanov A, Rabinow BE, Gong N, Mosley RL, Dou H, Boska MD, Gendelman HE. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One. 2009;4:e4343.
25. Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotech J. 2011;6:1342-7.
26. Rumenapp C, Gleich B, Haase A. Magnetic nanoparticles in magnetic resonance imaging and diagnostics. Pharm Res. 2012;29:1165-79.
27. Qiao RR, Yang CH, Gao MY. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem. 2009;19:6274-93.
28. Meenach SA, Hilt JZ, Anderson KW. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 2010;6:1039-46.
29. Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L, Dewey M, Laule M, Hamm B, Taupitz M. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans. J Magn Reson Imaging. 2011;34:816-23.
30. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomed. 2007;2:609-22.
31. Chanteau B, Fresnais J, Berret JF. Electrosteric enhanced stability of functional sub-10 nm cerium and iron oxide particles in cell culture medium. Langmuir. 2009;25:9064-70.
32. Goloverda G, Jackson B, Kidd C, Kolesnichenko V. Synthesis of ultrasmall magnetic iron oxide nanoparticles and study of their colloid and surface chemistry. J Magn Magn Mater. 2009;321:1372-6.
33. Park Y, Whitaker RD, Nap RJ, Paulsen JL, Mathiyazhagan V, Doerrer LH, Song YQ, Hurlimann MD, Szleifer I, Wong JY. Stability of superparamagnetic iron oxide nanoparticles at different pH values: experimental and theoretical analysis. Langmuir. 2012;28:6246-55.
34. Hatakeyama M, Kishi H, Kita Y, Imai K, Nishio K, Karasawa S, Masaike Y, Sakamoto S, Sandhu A, Tanimoto A, Gomi T, Kohda E, Abe M, Handa H. A two-step ligand exchange reaction generates highly water-dispersed magnetic nanoparticles for biomedical applications. J Mater Chem. 2011;21:5959-66.
35. Lattuada M, Hatton TA. Functionalization of monodisperse magnetic nanoparticles. Langmuir. 2007;23:2158-68.
36. Guo R, Song Y, Wang GL, Murray RW. Does core size matter in the kinetics of ligand exchanges of monolayer-protected Au clusters? J Am Chem Soc. 2005;127:2752-7.
37. Woehrle GH, Brown LO, Hutchison JE. Thiol-functionalized, 1.5-nm gold nanoparticles through ligand exchange reactions: scope and mechanism of ligand exchange. J Am Chem Soc. 2005;127:2172-83.
38. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF. The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials. 2011;32:9353-63.
39. Andreas K, Georgieva R, Ladwig M, Mueller S, Notter M, Sittinger M, Ringe J. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials. (2012).
40. Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloid Surface B. 2007;56:174-81.
41. Kim DH, Rozhkova EA, Rajh T, Bader SD, Novosad V. Synthesis of hybrid gold/iron oxide nanoparticles in block copolymer micelles for imaging, drug delivery, and magnetic hyperthermia. IEEE T Magn. 2009;45:4821-4.
42. Euliss LE, Grancharov SG, O'Brien S, Deming TJ, Stucky GD, Murray CB, Held GA. Cooperative assembly of magnetic nanoparticles and block copolypeptides in aqueous media. Nano Lett. 2003;3:1489-93.
43. Berret JF, Schonbeck N, Gazeau F, El Kharrat D, Sandre O, Vacher A, Airiau M. Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. J Am Chem Soc. 2006;128:1755-61.
44. Kim BS, Qiu JM, Wang JP, Taton TA. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett. 2005;5:1987-91.
45. Kim S, Shi YZ, Kim JY, Park K, Cheng JX. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Del. 2010;7:49-62.
46. Lee HJ, Bae Y. Cross-linked nanoassemblies from poly(ethylene glycol)-poly(aspartate) block copolymers as stable supramolecular templates for particulate drug delivery. Biomacromolecules. 2011;12:2686-96.
47. Scott D, Rohr J, Bae Y. Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity. Int J Nanomed. 2011;6:2757-67.
48. Ponta A, Akter S, Bae Y. Degradable cross-linked nanoassemblies as drug carriers for heat shock protein 90 inhibitor 17-N-allylamino-17- demethoxygeldanamycin. Pharmaceuticals. 2011;4:1281-92.
49. Frimpong RA, Dou J, Pechan M, Hilt JZ. Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation. J Magn Magn Mater. 2010;322:326-31.
50. O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421-6.
51. Forrest ML, Yanez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharm Res. 2008;25:194-206.
52. Tantra R, Tompkins J, Quincey P. Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension. Colloid Surface B. 2010;75:275-81.
53. Allouni ZE, Cimpan MR, Hol PJ, Skodvin T, Gjerdet NR. Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium. Colloid Surface B. 2009;68:83-7.
54. Foucaud L, Wilson MR, Brown DM, Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol Lett. 2007;174:1-9.
55. Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater. 2005;293:483-96.
56. Varanda LC, Jafelicci M, Tartaj P, O' Grady K, Gonzalez-Carreno T, Morales MP, Munoz T, Serna CJ. Structural and magnetic transformation of monodispersed iron oxide particles in a reducing atmosphere. J Appl Phys. 2002;92:2079-85.
57. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93-102.
58. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009;20:455101-9.
59. Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 2010;4:6303-17.
60. Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32:2183-93.
61. Khan MI, Mohammad A, Patil G, Naqvi SA, Chauhan LK, Ahmad I. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials. 2012;33:1477-88.
62. Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials. 2003;24:4551-7.
63. Soenen SJ, De Cuyper M. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine. 2010;5:1261-75.
64. Hu JM, Qian YF, Wang XF, Liu T, Liu SY. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging. Langmuir. 2012;28:2073-82.
65. Kiyatkin EA, Sharma HS. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience. 2009;161:926-39.